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among unstratified patients who undergo treatment with
elective surgical repair34-36 and the following risk-stratified
perioperative mortality rates: 0 to 1% among patients in
The Society for Vascular Surgery and The International
Society for Cardiovascular Surgery risk stratum 0, 1% to
3% among patients in risk stratum 1, 3% to 8% among
patients in risk stratum 2, and 8% to 30% among patients
in risk stratum 3.37,38 In addition, results of a recently
published report of 16,450 patients (average age, 72 ± 7
years) from the Nationwide Inpatient Sample who under-
went elective open surgical AAA repair during the period
from 1994 to 1996 revealed an in-hospital mortality rate
(underestimation of the true total perioperative or 30-day
mortality rate) of 4.2% and an overall complication rate of
32.4%.39 The perioperative mortality rate increased with
age, with female gender, with cerebrovascular occlusive
disease, with preoperative renal insufficiency, and with
more than three comorbidities. It is easy to see why, after
each preoperative evaluation, a skilled clinician and
informed patient together must decide whether and when
to operate, with the weight of evidence from the literature
and the patient’s individual risk assessment as guides.
Obviously, not all patients have ideal or even suitable con-
ditions for open AAA repair. What, then, becomes of the
patients who do not undergo treatment?
Recently, Conway et al40 reported a 10-year follow-up
study in which 106 patients with AAAs of more than 5.5
cm in diameter did not undergo treatment. At the end of
the study, 76 patients (71.7%) had died.40 In this select
study population of patients with conditions that were
unsuitable for surgery, the poor 10-year survival rate is not
exactly a revelation. However, the study results also
revealed AAA rupture as the cause of death in 36% of the
patients with AAA diameters of 5.5 to 5.9 cm at baseline,
in 50% of the patients with AAA diameters of 6.0 to 7.0
cm at baseline, and in 55% of the patients with AAA diam-
eters of more than 7.0 cm at baseline. The median survival
rate in the latter group was 9 months. How might the spe-
cific management chosen and the long-term survival rate
A growing worldwide experience with transluminal
endografting (TE) of abdominal aortic aneurysms (AAAs)
and the United States Food and Drug Administration’s
late 1999 approval of two devices for commercialization
have combined to produce a surge of interest in this less
invasive form of therapy.1-24 The brief training programs
provided by the manufacturers have served to increase the
number of operators and clinical sites involved. But the
proper place of TE in the armamentarium of AAA man-
agement has yet to be elucidated, and a variety of major
problems and limitations of the new method have begun
to surface. In addressing these problems, it should be pos-
sible from the available published data to formulate plans
for clinical investigation and technology development that
will advance knowledge and practice in TE through
attempts to overcome existing shortcomings. In the fol-
lowing opinion, patient selection, posttreatment surveil-
lance, current design limitations, and a rationale for
careful study of transrenal fixation are all addressed.
The late survival rate after successful open surgical
AAA repair has been reported to be approximately 67% at
5 years.25 Coronary heart disease contributes significantly
to both perioperative morbidity and mortality rates and to
late mortality rates in patients who undergo treatment.26-
33 Pulmonary disease, renal dysfunction, and advanced age
also add risk. For conventional AAA repair, the published
results document a 3% to 7% perioperative mortality rate
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in this study have been altered by the availability and appli-
cation of TE?
Two United States Food and Drug Administration–
approved AAA endografts and several other investigational
ones are in use in the United States today. Because TE is
relatively new and because comparatively few studies have
included mid-term and late outcomes,4,5,7,10,15,17,22-24,41
significantly less is known about TE than about conven-
tional operation.39,42-47 Important questions remain
about the durability and completeness of protection from
AAA rupture provided,22,41,48,49 about late complications
as the result of changes in AAA morphology23,24,50-54 or
as the result of endograft failure, about intermediate-term
and long-term patency rates,55 and about the role of TE
in subgroups that range from the highest risk with short-
est infrarenal aortic necks56,57 and other suboptimal
anatomy to the lowest risk with younger healthier patients
with small AAAs.58,59
Although TE is appealing because it is inherently less
invasive than conventional open repair, it has its own
shortcomings, one of the most important of which is the
problem of endoleaks.22,41,48,49,53,60,61 Although they are
not unique to TE, late post-treatment AAA ruptures do
occur and have become a cause for concern.61-64 From the
results of the limited reports available, it appears that late
AAA rupture after TE occurs in 1% or fewer patients.
However, long-term follow-up results comparable with
those of open repair are still not available. Therefore, this
number may be falsely low. Nevertheless, it is already clear
that although TE confers durable protection against AAA
rupture on treated populations, that protection is not
absolute in patients with endoleaks because late AAA
enlargement and even rupture can occur in these patients.
Given current knowledge, technology, and practice, close
surveillance after TE with the inclusion of contrast-
enhanced spiral computed tomographic (CT) scanning is
essential and has been emphasized by the United States
Food and Drug Administration.63
Late ruptures after apparently successful TE are com-
plex phenomena with potentially multifactorial causes. The
following factors are among the potential contributions to
the problem in any given case: 1, poor patient selection; 2,
operator/procedure-related factors; 3, device-related fac-
tors; and 4, anatomic-pathologic factors. Whatever the
causes of late AAA rupture after TE, the facts and theory
to date invoke endoleakage as the common underlying
pathophysiologic state that allows the AAA sac to remain
pressurized (early or immediate endoleak) or to resume a
pressurized state (late-onset endoleak). Type IA (proximal
attachment) endoleaks are considered to be the most omi-
nous.60 Endoleakage shown with imaging is not univer-
sally accepted as a precondition for AAA enlargement after
TE because enlargement and rupture have been known to
occur in patients whose serial CT scan results failed to
show endoleaks. Increased pressure has been documented
in AAA sacs after TE in the absence of endoleaks shown
on CT scan results.50 Such experiences have led to the use
of the term, “endotension,” which refers to the situation
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of a pressurized AAA sac after TE without endoleak on CT
scan results.41 Experts in CT scan imaging, however, have
criticized reports of CT scan results that fail to document
endoleaks in patients with growing AAAs. They emphasize
the importance of specific CT scan imaging protocols that
are adequate for the detection of endoleaks.65
Poor patient selection involves inclusion of the follow-
ing patients: patients with no infrarenal aortic neck or
pyramidal shape of aortic neck from renal arteries caudad
to the level of the AAA; those patients with extensive
thrombus or plaque in the infrarenal aortic neck, which
often indicates that the “neck” is involved with the AAA
and that there is no adequate attachment zone; and those
patients with marked angulation between the infrarenal
aortic neck and the main axis of the AAA or between the
upper abdominal aorta and the infrarenal neck. In the
process of deployment, the latter condition may result in
the proximal endograft attachment “seeking” but not
“finding” the entire wall for anchoring. The result may be
caudal displacement of the proximal attachment and a
potentially compromised proximal seal. Depending on the
particular design, marked angulation may also compro-
mise endograft function in other ways (see subsequently).
The operator/procedure-related factors that may be
responsible include the following conditions: inadequate
oversizing of the proximal attachment for the diameter of
the infrarenal aortic neck, excessive oversizing of the prox-
imal attachment (may cause pleating of the graft and resul-
tant type IA endoleak), lower-than-ideal placement of the
proximal attachment in the infrarenal aortic neck,
improper sizing of the distal ends of the graft endolegs in
ectatic/aneurysmal iliac vessels (type IB endoleak), insuf-
ficient overlap of modular graft components (type III
endoleak), and other deployment errors.
The device-related factors include the following con-
ditions: modularity instead of unibody construction;
lack of an attachment mechanism for the prevention of
migration; potential aortic wall weakening as the result
of continuous pressure from expanded attachment
devices, which may lead to an increase in infrarenal aor-
tic neck diameter and late type IA endoleak; changes in
graft position or in the relative positions of components
over time because of either multiple cycles or actual
morphologic change in the AAA and aorta after initially
successful exclusion; other changes in position that
result from kink resistance or column strength in the
presence of changing AAA and aortic morphology; graft
fabric holes or tears as the result of failure of the graft
material or damage to the graft material by intact 
or fractured (caused by metal fatigue) metallic members
of the device or even calcified plaque contacting the
graft material; failure of attachment components; and
finally obligatory infrarenal attachment (no transrenal/
suprarenal attachment option) because of endograft
design. In our own experience,61 type IA endoleaks have
occurred in 3.6% of the cases that involve transrenal fix-
ation versus in 5.0% of the cases that involve infrarenal
fixation, for an odds ratio of 1.4.
The anatomic-pathologic factors that predispose a
patient to endoleak, AAA enlargement, and potential rup-
ture include the following conditions: lack of complete
incorporation of the attachment components into the aortic
wall;66 large collateral anastomoses65 between the iliolum-
bar branches of the internal iliac artery and the lumbar
branches of the aorta, which lead to type II endoleak; native
arterial anastomoses between the left branch of the middle
colic artery and the left colic branch of the inferior mesen-
teric artery, with a patent inferior mesenteric trunk arising
from the aorta, which also lead to type II endoleak; short-
ening of the AAA or the aorta and iliac arteries after TE,
with resultant migration or relative migration of the endo-
prosthesis or its components, which may cause type IA, IB,
or III endoleak; and finally continued enlargement in the
diameter of the AAA infrarenal neck after treatment that is
attributable to aging or to the disease itself. Obviously, the
latter condition can result in late type IA endoleak, AAA
enlargement, and rupture. Other investigators have estab-
lished that enlargement of the AAA infrarenal neck after
treatment without enlargement of the suprarenal aorta can
and does occur51,67 and may be associated with endograft
migration and late endoleak.23,68 Infrarenal aortic neck
dilatation occurs even after conventional operation.69 In
one small CT scan study of 19 patients who underwent
open AAA repair, Sonesson and colleagues70 showed that
the infrarenal neck, the aortic diameter at the level of the
renal arteries, and the diameter at the level of the superior
mesenteric artery all had increased at a mean follow-up
period of 6 years after surgery but that the rate of increase
was the least above the renal arteries. AAA neck enlarge-
ment may be limited or pose no danger in the presence of a
suture anastomosis of conventional open repair. However,
the potential danger is obvious in the case of TE.
Unfortunately, it is unclear how to reliably predict which
infrarenal aortic necks will enlarge the most or the fastest
after endografting and which patients will have type IA
endoleaks develop. Not surprisingly, thus far, we are also
unable to answer complex questions, such as whether
increased AAA sac pressures associated with type II
endoleaks50 can, with time, contribute to infrarenal neck
dilatation and the onset of late type IA or type III endoleaks.
All of these facts and questions underscore today’s depen-
dence of operators and patients on the specific attachment
mechanism. However, because the usual situation in prac-
tice today finds the operator lacking control over endograft
features and their mechanisms of operation, the specific
attachment site that is chosen looms as extremely important.
With all of the aforementioned, there is an abundance
of rationale for further study of transrenal endograft fixa-
tion. Endografting immediately below the renal arteries,
with use of bare metal spring attachments across the renal
arteries and onto the suprarenal segment of the aorta,
offers the greatest potential (given currently available
technology) to minimize concerns about late enlargement
of the infrarenal aortic neck. Branched endograft designs
are forthcoming,71 but for now they cannot be considered
an option in TE of AAAs.
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Little has been written about the results and conse-
quences of transrenal fixation.56,57,72,73 Malina and col-
leagues72 crossed 25 renal arteries with bare metal spring
in 18 patients with AAAs who underwent endografting.
In their follow-up period to a median of 6 months, all the
arteries remained patent, there was no effect on serum
creatinine levels, and only one patient had evidence of a
small infarct in one kidney on follow-up CT scan results.
In a series by Bove and colleagues73 with a median fol-
low-up period of 6 months, 28 patients underwent AAA
treatment with the use of the Talent LPS bifurcated endo-
graft (Medtronic, Sunrise, Fla) with use of transrenal fix-
ation. No renal infarcts were detected with follow-up CT
scanning, and only one patient of the 19 with healthy pre-
operative renal function had a persistent elevation of cre-
atinine level after surgery.
In our own experience, 222 patients (73%) underwent
endgrafting with infrarenal fixation (IF) and 83 (27%)
underwent transrenal fixation (TF). Preoperative and
postoperative serum creatinine levels and follow-up serum
creatinine levels were obtained. These laboratory values
and inspection of the renal parenchyma on follow-up AAA
CT scans in a subset of 100 patients failed to yield con-
vincing evidence of embolic problems or of a negative
impact of TF on renal function. Overall, creatinine clear-
ance declined an average of 5 mL/min in the transrenal
group but remained stable in the infrarenal group.
Nevertheless, the sample size was small, patient character-
istics differed between the infrarenal fixation and TF
groups, and the data were not definitive. Clearly, more
studies of TF are needed.
In summary, several related phenomena late after TE,
including infrarenal aortic neck enlargement, type IA
endoleaks, AAA enlargement, and AAA rupture, firmly
establish the rationale for seeking the renal and suprarenal
segments of the aorta as the ideal sites for proximal fixa-
tion. However, it is unclear whether TF negatively impacts
renal function and, if it does, whether the impact out-
weighs the apparent advantage of TF. Thus, studies are
urgently needed to track and describe in detail the changes
that occur in the aorta and in the kidneys after endovascu-
lar AAA repair with TF, with the Talent LPS, the Cook
Zenith endograft (Cook, Inc, Bloomington, Ind), and
other suitable endograft designs. Ultimately, it may prove
important to include in these studies subjects from all The
Society for Vascular Surgery and The International Society
for Cardiovascular Surgery risk strata 0 through 3.
However, given currently available technology and results,
the youngest patients with AAA with the greatest life
expectancy still remain the best candidates for open AAA
repair and the poorest candidates for TE. Most impor-
tantly, there is much more needed than just additional clin-
ical data. There is a glaring clinical need for technologic
improvements in the proximal fixation mechanisms of
endografts. In the future, perhaps newer endograft designs
with excellent attachment mechanisms and low frequencies
of late failure will provide better therapeutic options to
most patients with AAA.
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